PRACRITI
PRACRITI predicts COVID-19 transmission dynamics at granular geographical scales using an adaptive, interacting, cluster-based mathematical modeling approach to estimate incidence, effective reproduction number (R_t), and asymptomatic/undetected infections.
Key Features:
- Adaptive Modeling: PRACRITI employs an adaptive framework that adjusts to spatial variations in the effective reproduction number (R_t).
- Interacting Cluster-Based Modeling: The tool uses interacting cluster-based mathematical models to analyze transmission across administrative units including districts and states.
- Granular Predictions and Forecasting: It produces district- and state-level incidence forecasts and R_t estimates, including three-week case projections, tested on incidence data from Italy, the United States, and India.
- Estimation of Asymptomatic and Undetected Cases: PRACRITI estimates asymptomatic and undetected infections to account for hidden transmission in incidence estimates.
Scientific Applications:
- Resource Allocation: Forecasting potential hotspots and case numbers to inform allocation of hospital beds, ventilators, and healthcare personnel.
- Control Strategy Design: Enabling design of targeted interventions such as lockdowns, testing campaigns, and vaccination drives based on regional transmission trajectories.
- Public Health Planning: Supporting preparation for subsequent waves and long-term public health planning through scenario-based forecasts.
Methodology:
Adaptive, interacting, cluster-based mathematical modeling with estimation of effective reproduction number (R_t) and asymptomatic/undetected cases applied to incidence data from Italy, the United States, and India to generate district- and state-level forecasts including three-week case projections.
Topics
Details
- Added:
- 1/18/2021
- Last Updated:
- 1/27/2021
Operations
Publications
Ravinder R, Singh S, Bishnoi S, Jan A, Sharma A, Kodamana H, Krishnan NA. An adaptive, interacting, cluster-based model for predicting the transmission dynamics of COVID-19. Heliyon. 2020;6(12):e05722. doi:10.1016/j.heliyon.2020.e05722. PMID:33367130. PMCID:PMC7749387.